Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

International risk of SARS-CoV-2 Omicron variant importations originating in South Africa

Yuan Bai, Zhanwei Du, Mingda Xu, Lin Wang, Peng Wu, View ORCID ProfileEric H. Y. Lau, Benjamin J. Cowling, View ORCID ProfileLauren Ancel Meyers
doi: https://doi.org/10.1101/2021.12.07.21267410
Yuan Bai
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhanwei Du
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingda Xu
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Wang
3University of Cambridge, Cambridge CB2 3EH, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Wu
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric H. Y. Lau
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric H. Y. Lau
Benjamin J. Cowling
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Ancel Meyers
4The University of Texas at Austin, Austin, Texas 78712, The United States of America
5Santa Fe Institute, Santa Fe, New Mexico, The United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren Ancel Meyers
  • For correspondence: laurenmeyers{at}austin.utexas.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Omicron, a fast-spreading SARS-CoV-2 variant of concern reported to the World Health Organization on November 24, 2021, has raised international alarm. We estimated there is at least 50% chance that Omicron had been introduced by travelers from South Africa into all of the 30 countries studied by November 27, 2021.

South Africa (SA) first detected the B.1.1.529 SARS-CoV-2 variant from a specimen collected on November 9, 2021 and reported the variant to the World Health Organization (WHO) on November 24, 2021 (1). Two days later, the WHO named the variant Omicron and classified it as a Variant of Concern (VOC), because of increasing detections in South Africa and large number of mutations in immunogenic regions of the spike protein (1). In addition to increasing cases in South Africa, the new variant may have been prevalent in other locations in southern Africa. By November 30, 2021, over 11 countries had reported detections of the Omicron variant, with the first reports of international importations coming from Hong Kong, Israel, Japan, and France (2). Three days later, it was reported in 29 additional countries (2). As of December 2, 2021, more than 50 countries had enacted border controls to slow the global spread of Omicron (3). For example, Japan and Israel closed their borders to all foreign travelers (4). The Omicron variant might have been spreading cryptically in these and other countries before the WHO declaration, undetected because of limited viral sequencing capacity.

Since South Africa has strong travel links with the rest of the world and was known to have early cases of the Omicron variant, we analyzed population mobility data from SA to 30 non-African countries with direct flights in the study period, available through Facebook Data for Good and OpenSky (Table S1), as well as Omicron case report data from SA (2). We estimated the probability that the Omicron variant was introduced into each country via travelers from SA and the extent of local transmission prior to November 28, 2021 (detailed in Appendix). Hungary has the highest expected importation risk between November 1 and November 28, 2021, with a date of introduction of November 23 exceeding a 50% chance. By the time Omicron was classified as a VOC (November 26), we estimated that 26 of the 30 non-African regions had over a 50% chance of having received at least one travel-based importation from SA (Figure 1). The remaining four countries––United Kingdom (UK), Switzerland, France, and Sweden––exceeded this risk threshold on November 27. By December 3, 18 of the 30 regions had confirmed Omicron cases (2). If Omicron was also prevalent in other countries in southern Africa the above estimates would be underestimates of the probability of importation in other parts of the world.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Estimated risks of SARS-CoV-2 Omicron variant introductions from South Africa to 30 non-African regions on or before November 28, 2021.

(A) The probability that at least one person infected with the Omicron variant arrived in a given country from South Africa by the date indicated on the x-axis, based on Facebook mobility and OpenSky data. The black dashed vertical line indicates November 26, 2021, when the WHO classified Omicron as a VOC (1); the red dashed horizontal line indicates an importation probability of 50%; line colors correspond to the relative risk of importations as of November 26. Regions that confirmed Omicron cases by December 3, 2021 are listed in black (2). (B) Probability of at least one Omicron variant importation from SA by November 28, 2021. Regions in grey were not analyzed because mobility data were not available.

Regions that receive a substantial number of travelers from South Africa were likely to harbor cases of the Omicron variant by late November 2021. Although the UK has lower estimated importation risks than many of the other regions considered, it has reported the largest number of Omicron cases outside Africa, as of November 29 (2). This reflects the UK’s strong genomic surveillance program, which has contributed nearly 25% of all SARS-CoV-2 sequences globally (5), and suggests that Omicron may be spreading undetected in countries with similar or higher importation risks but perhaps less sequencing capacity.

Our estimates rest on several simplifying assumptions. The Facebook mobility data, which included ∼93 thousand trips from SA to the 30 non-African regions, reflects the demographic makeup of the user base, with ∼2.9 billion monthly active users in the third quarter of 2021 (6). The Facebook data exclude date-destination combinations for which the total number of travelers from SA is less than 1000. We fill in those missing data assuming a constant ratio between the number of travelers and the number of available seats on flights, which we estimate from a combination of the Facebook and OpenSky data (detailed in Appendix). We assumed that all introductions during this early period occurred via pre-symptomatic and asymptomatic travelers from SA and ignored possible importations from other countries or by symptomatic cases. Thus, we may underestimate the risks. Furthermore, we assumed a 10-day lag between infection and hospitalization based on estimates from the United States (7) and Europe (8), under the assumption that the wildtype and Omicron variants share the same natural history of infection and symptomatic proportion. Should future studies reveal significant epidemiological differences between the Omicron variant and the wildtype, then these estimates can be readily updated.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Acknowledgments

Financial support was provided by the Collaborative Research Fund (Project No. C7123-20G) of the Research Grants Council of the Hong Kong SAR Government, the US National Institutes of Health (grant no. R01 AI151176), and the Centers for Disease Control and Prevention COVID Supplement (grant no. U01IP001136).

References

  1. 1.↵
    Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern [Internet]. [cited 2021 Nov 30]. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
  2. 2.↵
    GISAID -hCov19 Variants [Internet]. [cited 2021 Nov 30]. Available from: https://www.gisaid.org/hcov19-variants/
  3. 3.↵
    Mallapaty S. Omicron-variant border bans ignore the evidence, say scientists. Nature [Internet]. 2021 Dec 2 [cited 2021 Dec 4]; Available from: https://www.nature.com/articles/d41586-021-03608-x
  4. 4.↵
    Torjesen I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ [Internet]. 2021 Nov 29 [cited 2021 Nov 30];375. Available from: https://www.bmj.com/content/375/bmj.n2943
  5. 5.↵
    UK Health Security Agency. UK completes over one million SARS-CoV-2 whole genome sequences [Internet]. GOV.UK. 2021 [cited 2021 Dec 4]. Available from: https://www.gov.uk/government/news/uk-completes-over-one-million-sars-cov-2-whole-genome-sequences
  6. 6.↵
    Number of monthly active Facebook users worldwide as of 3rd quarter 2020 [Internet]. [cited 2021 Jan 3]. Available from: https://www.statista.com/statistics/264810/number-of-monthly-active-facebook-users-worldwide/
  7. 7.↵
    Aleta A, Martín-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, et al. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav. 2020 Aug 5;4(9):964–71.
    OpenUrl
  8. 8.↵
    ISARIC. International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). COVID-19 Report: 19 [Internet]. 2020 [cited 2021 Feb 1]. Available from: https://media.tghn.org/medialibrary/2020/05/ISARIC_Data_Platform_COVID-19_Report_19MAY20.pdf
Back to top
PreviousNext
Posted December 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
International risk of SARS-CoV-2 Omicron variant importations originating in South Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
International risk of SARS-CoV-2 Omicron variant importations originating in South Africa
Yuan Bai, Zhanwei Du, Mingda Xu, Lin Wang, Peng Wu, Eric H. Y. Lau, Benjamin J. Cowling, Lauren Ancel Meyers
medRxiv 2021.12.07.21267410; doi: https://doi.org/10.1101/2021.12.07.21267410
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
International risk of SARS-CoV-2 Omicron variant importations originating in South Africa
Yuan Bai, Zhanwei Du, Mingda Xu, Lin Wang, Peng Wu, Eric H. Y. Lau, Benjamin J. Cowling, Lauren Ancel Meyers
medRxiv 2021.12.07.21267410; doi: https://doi.org/10.1101/2021.12.07.21267410

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3252)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1013)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4899)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (538)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4192)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)